Thyroid Pathology in High-Risk Cardiac Surgery Patients with Coronary Artery Disease

Q4 Medicine
O. Gogayeva, A. Rudenko, V. Lazoryshynets, S. A. Rudenko, T. A. Andrushchenko
{"title":"Thyroid Pathology in High-Risk Cardiac Surgery Patients with Coronary Artery Disease","authors":"O. Gogayeva, A. Rudenko, V. Lazoryshynets, S. A. Rudenko, T. A. Andrushchenko","doi":"10.30702/ujcvs/22.30(01)/gr009-0914","DOIUrl":null,"url":null,"abstract":"The aim. To analyze the features of the perioperative period in high-risk cardiac surgery patients with coronary artery disease (CAD) and thyroid disease. \nMaterials and methods. Retrospective analysis of data of 354 high-risk patients with CAD who were operated and discharged from the National Amosov Institute of Cardiovascular Surgery of the NAMS of Ukraine from 2009 to 2019. All the patients underwent standard clinical and laboratory tests, ECG, echocardiography, coronary angiography and surgical myocardial revascularization with correction of concomitant cardiac pathology. Ultrasound screening of thyroid disease and thyroid hormone levels was not performed in all patients, however, patients with severe symptoms were referred for follow-up. \nResults. Thyroid disease was diagnosed in 37 (10.4%) patients, of whom 11 (3.1%) had hypothyroidism and were receiving hormone replacement therapy, and 1 (0.28%) had hyperthyroidism on tyrosol therapy. Ultrasound signs of thyroiditis were detected in 7 (1.9%) patients, nodular goiter in 29 (8.1%), and retrosternal goiter in 1 (0.28%) patient. Dependingonthecardiacsurgicalpathology,theprevalenceofhypothyroidismdidnotdifferinpatientswithuncomplicated and complicated forms of CAD (7 [3.6%] and 4 [2.5%] patients, respectively, p = 0.5498). Patients with hypothyroidism received hormone replacement therapy with levothyroxine in a dosage prescribed by an endocrinologist. The day before the surgery, thyroid-stimulating hormone control was performed to confirm the achievement of compensation. When comparing the course of the operative period in compensated hypothyroidism and clinical euthyroidism, no significant differences were found, and the postoperative period didn’t differ in the occurrence of atrial fibrillation (p = 0.0801), hydrothorax (p = 0.5280), but a decrease in the estimated glomerular filtration rate at discharge was found in patients with hypothyroidism (59.5 ± 16.8 vs. 71.3 ± 19.6 ml/min/1.73 m2, p = 0.0493). \nConclusions. Timely detection of thyroid dysfunction allows to compensate the condition and avoid postoperative complications. Analysis of the perioperative period in patients with hypothyroidism showed no effect of compensated hypothyroidism on the operative and postoperative periods in high-risk patients with CAD. Decreased glomerular filtration rate after surgery in patients with hypothyroidism requires further study and adherence to the strategy of nephroprotection in polymorbid patients.","PeriodicalId":33680,"journal":{"name":"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30702/ujcvs/22.30(01)/gr009-0914","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The aim. To analyze the features of the perioperative period in high-risk cardiac surgery patients with coronary artery disease (CAD) and thyroid disease. Materials and methods. Retrospective analysis of data of 354 high-risk patients with CAD who were operated and discharged from the National Amosov Institute of Cardiovascular Surgery of the NAMS of Ukraine from 2009 to 2019. All the patients underwent standard clinical and laboratory tests, ECG, echocardiography, coronary angiography and surgical myocardial revascularization with correction of concomitant cardiac pathology. Ultrasound screening of thyroid disease and thyroid hormone levels was not performed in all patients, however, patients with severe symptoms were referred for follow-up. Results. Thyroid disease was diagnosed in 37 (10.4%) patients, of whom 11 (3.1%) had hypothyroidism and were receiving hormone replacement therapy, and 1 (0.28%) had hyperthyroidism on tyrosol therapy. Ultrasound signs of thyroiditis were detected in 7 (1.9%) patients, nodular goiter in 29 (8.1%), and retrosternal goiter in 1 (0.28%) patient. Dependingonthecardiacsurgicalpathology,theprevalenceofhypothyroidismdidnotdifferinpatientswithuncomplicated and complicated forms of CAD (7 [3.6%] and 4 [2.5%] patients, respectively, p = 0.5498). Patients with hypothyroidism received hormone replacement therapy with levothyroxine in a dosage prescribed by an endocrinologist. The day before the surgery, thyroid-stimulating hormone control was performed to confirm the achievement of compensation. When comparing the course of the operative period in compensated hypothyroidism and clinical euthyroidism, no significant differences were found, and the postoperative period didn’t differ in the occurrence of atrial fibrillation (p = 0.0801), hydrothorax (p = 0.5280), but a decrease in the estimated glomerular filtration rate at discharge was found in patients with hypothyroidism (59.5 ± 16.8 vs. 71.3 ± 19.6 ml/min/1.73 m2, p = 0.0493). Conclusions. Timely detection of thyroid dysfunction allows to compensate the condition and avoid postoperative complications. Analysis of the perioperative period in patients with hypothyroidism showed no effect of compensated hypothyroidism on the operative and postoperative periods in high-risk patients with CAD. Decreased glomerular filtration rate after surgery in patients with hypothyroidism requires further study and adherence to the strategy of nephroprotection in polymorbid patients.
冠心病高危心脏外科患者的甲状腺病理学
目标。分析冠心病和甲状腺疾病高危心脏手术患者围手术期的特点。材料和方法。对2009年至2019年乌克兰NAMS国家阿莫索夫心血管外科研究所手术和出院的354名CAD高危患者的数据进行回顾性分析。所有患者均接受了标准的临床和实验室检查、心电图、超声心动图、冠状动脉造影和外科心肌血运重建,并纠正了伴随的心脏病理。并非所有患者都进行了甲状腺疾病和甲状腺激素水平的超声筛查,但症状严重的患者被转诊进行随访。后果37名(10.4%)患者被诊断为甲状腺疾病,其中11名(3.1%)患有甲状腺功能减退症并正在接受激素替代治疗,1名(0.28%)患有甲状腺机能亢进症并接受酪醇治疗。甲状腺炎超声征象7例(1.9%),结节性甲状腺肿29例(8.1%),胸骨后甲状腺肿1例(0.28%)。根据心脏外科病理学,甲状腺功能减退症的评估在无并发症和复杂形式CAD的患者中没有差异(分别为7[3.6%]和4[2.5%],p=0.5498)。甲状腺功能减退患者接受了内分泌学家规定剂量的左甲状腺素激素替代治疗。手术前一天,进行了促甲状腺激素控制,以确认补偿的实现。当比较补偿性甲状腺功能减退症和临床甲状腺功能正常症的手术期过程时,没有发现显著差异,术后心房颤动(p=0.0801)、胸腔积液(p=0.5280)、,但甲状腺功能减退患者出院时估计的肾小球滤过率降低(59.5±16.8 vs.71.3±19.6 ml/min/1.73 m2,p=0.0493)。及时发现甲状腺功能障碍可以补偿病情,避免术后并发症。对甲状腺功能减退患者围手术期的分析显示,代偿性甲状腺功能减退对CAD高危患者的手术期和术后期没有影响。甲状腺功能减退患者术后肾小球滤过率降低需要进一步研究并坚持多发性疾病患者的肾保护策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
42
审稿时长
6 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信